Venetoclax plus intensive chemotherapy with cladribine, idarubicin, and cytarabine in patients with newly diagnosed acute myeloid leukaemia or high-risk myelodysplastic syndrome: a cohort from a single-centre, single-arm, phase 2 trial
2021 ◽
Vol 8
(8)
◽
pp. e552-e561
◽
Keyword(s):
Phase 2
◽
2020 ◽
Vol 7
(8)
◽
pp. e566-e574
◽
2018 ◽
Vol 19
(12)
◽
pp. 1668-1679
◽
2015 ◽
Vol 16
(16)
◽
pp. 1691-1699
◽
2015 ◽
Vol 2
(10)
◽
pp. e396-e397
◽
Keyword(s):